ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ÀûÀÀÁõº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Non-steroidal Anti-inflammatory Drugs Market Size, Share & Trends Analysis Report By Disease Indication (Arthritis, Ophthalmic Diseases), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1611201
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,269,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,659,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,438,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦ ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦ ½ÃÀå ±Ô¸ð´Â 2025-2030³â µ¿¾È 5.66%ÀÇ CAGRÀ» ±â·ÏÇϸç 2030³â±îÁö 312¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦´Â ÁÖ·Î ¿°Áõ°ú ÅëÁõÀ» ¿ÏÈ­Çϰí ü¿Â »ó½ÂÀ» ³·Ãß±â À§ÇØ »ç¿ëµÇ´Â ¾à¹°ÀÔ´Ï´Ù. »ý¸®Åë, µÎÅë, ¹ß¿­, °üÀý¿°, ¿°ÁÂ, ±äÀå ¹× ±âŸ ¸¸¼º ÅëÁõ°ú °°Àº Áõ»ó ¿ÏÈ­¸¦ À§ÇÑ ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦(NSAID)ÀÇ Ã³¹æ·üÀÌ ³ô¾Æ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦ ½ÃÀåÀº ³ë³âÃþ¿¡¼­ ÀÌ·¯ÇÑ ÁúȯÀÇ ³ôÀº À¯º´·ü°ú ÇÔ²² Àü ¼¼°èÀûÀ¸·Î Ç¥Àû Áúȯ ¹× ¸¸¼º ÅëÁõÀÇ À¯º´·ü Áõ°¡¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ ¼ºÀå ±âȸ¸¦ ¸ñ°ÝÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, OTC NSAIDs¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í µÎÅë, ÆíµÎÅë, »ý¸®Åë¿¡ ´ëÇÑ NSAIDsÀÇ Ã¤Åà Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, °üÀý¿° ¹× ±âŸ ÅëÁõ °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡µµ ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, ¿µ±¹, ÇÁ¶û½º, µ¶ÀÏÀº ´Ù¸¥ À¯·´ ±¹°¡µé¿¡ ºñÇØ °ñ°üÀý¿° À¯º´·üÀÌ ³ô½À´Ï´Ù. °üÀý¿°ÀÇ À¯º´·üÀº ½Åü Ȱµ¿À» ¸¹ÀÌ ÇÏ´Â »ç¶÷Àϼö·Ï ³·À¸¸ç, ¿¬·ÉÀÌ ³ô¾ÆÁú¼ö·Ï À¯º´·üÀÌ ³ô¾ÆÁö´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. µû¶ó¼­ °üÀý¿° À¯º´·üÀÇ Áõ°¡µµ ¿¹Ãø ±â°£ µ¿¾È ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷µéÀº Àü ¼¼°èÀûÀ¸·Î ½ÃÀå Á¡À¯À²À» È®´ëÇϱâ À§ÇØ Áö¸®Àû È®Àå ¹× ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦ ¹èÇÕÁ¦ äÅðú °°Àº Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ äÅÃÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Alkem Labs¿Í Dr.Reddy's Laboratories Ltd´Â ¹Ì±¹¿¡¼­ ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦¸¦ Ãâ½ÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÅëÁõ °ü¸® ¹× ±âŸ ¿°Áõ¼º Áúȯ¿¡ ´ëÇÑ ÀÏ¹Ý ÀǾàǰÀÇ ½ÂÀÎ Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ¿Í °°ÀÌ ÁÖ¿ä ±â¾÷µéÀÌ Ã¤ÅÃÇÑ ´Ù¾çÇÑ Àü·«Àº ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

°¢±¹ Á¤ºÎ´Â ÆíµÎÅë, °üÀý¿° ¹× ±âŸ Áúº´ÀÇ ºÎ´ãÀ» ÁÙÀ̱â À§ÇØ ÀÚ±¹¿¡ À¯¸®ÇÑ ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ±¹¸³º¸°Ç¿ø(National Institutes of Health)Àº ÅëÁõ ¹× ¿°Áõ¼º Áúȯ °ü¸®¸¦ °³¼±Çϱâ À§ÇÑ ¿¬±¸ Ȱµ¿À» °¡¼ÓÈ­Çϱâ À§ÇØ HEALÀ» ½ÃÀÛÇß½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ Á᫐ °á°ú ¿¬±¸¼Ò(Patient-Centered Outcomes Research Institute)´Â ÅëÁõ¿¡ ´ëÇÑ ºñ¿ÀÇÇ¿ÀÀ̵å Ä¡·á ¿É¼ÇÀ» µµÀÔÇϱâ À§ÇÑ ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ¼ºÀå¼¼°¡ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦ ½ÃÀå : ÀûÀÀ Áúȯº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦ ½ÃÀå : Åõ¿© °æ·Îº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦ ½ÃÀå : À¯Åë ä³Îº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦ ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Non-steroidal Anti-inflammatory Drugs Market Growth & Trends:

The global non-steroidal anti-inflammatory drugs market size is estimated to reach USD 31.29 billion by 2030, registering a CAGR of 5.66% from 2025 to 2030, according to a new report by Grand View Research, Inc. Nonsteroidal anti-inflammatory drugs are drugs that are primarily used to relieve inflammation and pain, as well as to lower elevated body temperature. The high prescription rate of non-steroidal anti-inflammatory drugs (NSAIDs) for relief of symptoms of painful periods, headaches, fever, arthritis, sprains, strains, and other types of chronic pain is expected to drive the market during the forecast period.

The non-steroidal anti-inflammatory drugs market is expected to witness growth opportunities owing to factors such as the rising prevalence of targeted diseases and chronic pain across the globe, coupled with the high prevalence of these diseases in the geriatric population. Moreover, increasing demand for OTC NSAIDs and the rising adoption of NSAIDs for headaches, migraines, and menstrual pain are also expected to boost the growth during the forecast period.

Moreover, the increasing prevalence of arthritis and other pain-related disorders is also expected to support the growth. For instance, the prevalence of osteoarthritis is higher in the UK, France, and Germany compared to other countries in the Europe region. The prevalence of arthritis is seen to be lower in people who are often engaged in physical activities, and its prevalence rises with age. Thus, the rising prevalence of arthritis is also expected to cater to the growth during the forecast period.

Key market players are adopting strategic initiatives such as geographical expansion and the introduction of combination non-steroidal anti-inflammatory drugs to increase their market share across the globe. For instance, Alkem Labs and Dr. Reddy's Laboratories Ltd have launched their non-steroidal anti-inflammatory drugs in the U.S. Moreover, increasing approval of OTC drugs for pain management and other inflammatory diseases is expected to drive growth during the forecast period. Thus, owing to the various strategies adopted by key players, the market is likely to boost its growth.

Governments in various regions are undertaking favorable initiatives to reduce the burden of migraine, arthritis, and other diseases in their countries. For instance, the National Institutes of Health has initiated HEAL to accelerate research activities to improve the management of pain and inflammatory diseases. Moreover, the Patient-Centered Outcomes Research Institute has undertaken initiatives to introduce non-opioid treatment options for pain. Such initiatives are expected to increase growth during the forecast period.

Non-steroidal Anti-inflammatory Drugs Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Non-Steroidal Anti-Inflammatory Drugs Market Variables, Trends & Scope

Chapter 4. Non-Steroidal Anti-Inflammatory Drugs Market: Disease Indication Estimates & Trend Analysis

Chapter 5. Non-Steroidal Anti-Inflammatory Drugs Market: Route of Administration Estimates & Trend Analysis

Chapter 6. Non-Steroidal Anti-Inflammatory Drugs Market: Distribution Channel Estimates & Trend Analysis

Chapter 7. Non-Steroidal Anti-Inflammatory Drugs Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â